Your fact-checks will appear here
Clinical trials studying the use of ivermectin as a treatment for COVID-19
Mainstream medical agencies rejected primarily after a cascade of large, well-conducted (RCTs) failed to show clinical benefit, systematic reviews and Cochrane-level meta-analyses concluded no effect,...
as an anticancer agent is nascent: small, early-phase combination trials have used oral, pulsed schedules (for example, days 1–3, 8–10, 15–17 of a 21‑day cycle) alongside immune checkpoint inhibitors,...
There is no clinical evidence supporting long-term ivermectin use for cancer prevention, and medical authorities have not approved it for that purpose; therefore treating oneself chronically with iver...
Veterinary ivermectin misuse during the drove a measurable and well‑documented rise in poison‑control reports and a smaller but real increase in emergency‑department visits and hospitalizations tied t...
Clinical and forensic laboratories identify ivermectin and its metabolites primarily with liquid chromatography coupled to mass spectrometry — ranging from targeted LC‑MS/MS for quantification to ultr...